ScholarLens Back to search
2012•Transplantation and Cellular TherapyOpen access

Autologous and Allogenic Stem Cell Transplantation Results in Multiple Myeloma Patients – Single Center Study

Ardeshir Ghavamzadeh, Kamran Alimoghaddam, M. Jahani, Seied Asadollah Mousavi, Burak Bahar, Mohammad Reza Iravani, Fatemeh Ghaffari, Mahdi Jalili, Arash Jalali

Open full text 0 citations

Abstract

Multiple myeloma is a hematologic malignancy which best responses to high dose therapies (HDT). HDT with autologous stem cell transplantation (ASCT) is demonstrated for multiple myeloma treatment, although some studies suggest allogenic stem cell transplantation as better choice for younger patients. Several studies have shown the efficacy of intensive chemotherapy in increasing progression- free survival (PFS) and overall survival (OS) rates.

Open-access reader

About this research paper

What this paper is about

Multiple myeloma is a hematologic malignancy which best responses to high dose therapies (HDT). HDT with autologous stem cell transplantation (ASCT) is demonstrated for multiple myeloma treatment, although some studies suggest allogenic stem cell transplantation as better choice for younger patients. Several studies have shown the efficacy of intensive chemotherapy in increasing progression- free survival (PFS) and overall survival (OS) rates.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Multiple myeloma is a hematologic malignancy which best responses to high dose therapies (HDT). HDT with autologous stem cell transplantation (ASCT) is demonstrated for multiple myeloma treatment, although some studies suggest allogenic stem cell transplantation as better choice for younger patients. Several studies have shown the efficacy of intensive chemotherapy in increasing progression- free survival (PFS) and overall survival (OS) rates.

Key concepts: Medicine, Multiple myeloma, Autologous stem-cell transplantation, Single Center, Transplantation, Oncology, Stem cell, Malignancy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Autologous and Allogenic Stem Cell Transplantation Results in Multiple Myeloma Patients – Single Center Study — Research Paper | ScholarLens